150 related articles for article (PubMed ID: 26994846)
1. Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists.
Xue Y; Tang J; Ma X; Li Q; Xie B; Hao Y; Jin H; Wang K; Zhang G; Zhang L; Zhang L
Eur J Med Chem; 2016 Jun; 115():94-108. PubMed ID: 26994846
[TBL] [Abstract][Full Text] [Related]
2. Discovery of fused heterocyclic carboxamide derivatives as novel α7-nAChR agonists: Synthesis, preliminary SAR and biological evaluation.
Xue Y; He X; Yang T; Wang Y; Liu Z; Zhang G; Wang Y; Wang K; Zhang L; Zhang L
Eur J Med Chem; 2019 Nov; 182():111618. PubMed ID: 31434041
[TBL] [Abstract][Full Text] [Related]
3. [The structure-activity relationships of novel α7 nicotinic acetylcholine receptor agonists based on indolizine scaffold].
Li Q; Yang TY; Xue Y; Ma XZ; Tang JS; Zhang GS; Wang KW; Zhang LR
Yao Xue Xue Bao; 2016 Oct; 51(10):1584-94. PubMed ID: 29932605
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of a hybrid series of potent and selective agonists of α7 nicotinic acetylcholine receptor.
Nencini A; Castaldo C; Comery TA; Dunlop J; Genesio E; Ghiron C; Haydar S; Maccari L; Micco I; Turlizzi E; Zanaletti R; Zhang J
Eur J Med Chem; 2014 May; 78():401-18. PubMed ID: 24704613
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of 1,4-Diazobicylco[3.2.2]nonane derivatives as α7-Nicotinic acetylcholine receptor PET/CT imaging agents and agonists for Alzheimer's disease.
Wang S; Fang Y; Wang H; Gao H; Jiang G; Liu J; Xue Q; Qi Y; Cao M; Qiang B; Zhang H
Eur J Med Chem; 2018 Nov; 159():255-266. PubMed ID: 30296684
[TBL] [Abstract][Full Text] [Related]
6. Discovery, cocrystallization and biological evaluation of novel piperidine derivatives as high affinity Ls-AChBP ligands possessing α7 nAChR activities.
Yang X; Shen J; Jiang L; Li W; Yu M; Pan G; Yan Y; Zhang C; Jia W; Xiao L; Yu H; Chen H; Zheng Y; Yu L; Xie Q; Zhou L; Shao L
Eur J Med Chem; 2018 Dec; 160():37-48. PubMed ID: 30317024
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.
Beinat C; Banister SD; Herrera M; Law V; Kassiou M
CNS Drugs; 2015 Jul; 29(7):529-42. PubMed ID: 26242477
[TBL] [Abstract][Full Text] [Related]
8. Development of spiroguanidine-derived α7 neuronal nicotinic receptor partial agonists.
Hill MD; Fang H; Digavalli SV; Healy FL; Gallagher L; Post-Munson D; Chen P; Natale J; Benitex Y; Morgan D; Lodge N; Bristow L; Macor JE; Olson RE
Bioorg Med Chem Lett; 2017 Feb; 27(3):578-581. PubMed ID: 27993517
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of multifunctional ligands targeting acetylcholinesterase and alpha 7 nicotinic acetylcholine receptor.
Cieslikiewicz-Bouet M; Naldi M; Bartolini M; Pérez B; Servent D; Jean L; Aráoz R; Renard PY
Biochem Pharmacol; 2020 Jul; 177():114010. PubMed ID: 32360492
[TBL] [Abstract][Full Text] [Related]
10. Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure-activity relationships studies.
Peng W; Ding F
Eur J Pharm Sci; 2015 Aug; 76():119-32. PubMed ID: 25963024
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of a novel series of 4-heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR.
Iwuagwu C; King D; McDonald IM; Cook J; Zusi FC; Hill MD; Mate RA; Fang H; Knox R; Gallagher L; Post-Munson Amy Easton D; Miller R; Benitex Y; Siuciak J; Lodge N; Zaczek R; Morgan D; Bristow L; Macor JE; Olson RE
Bioorg Med Chem Lett; 2017 Mar; 27(5):1261-1266. PubMed ID: 28169167
[TBL] [Abstract][Full Text] [Related]
12. Investigations of amide bond variation and biaryl modification in analogues of α7 nAChR agonist SEN12333.
Beinat C; Reekie T; Hibbs D; Xie T; Olson TT; Xiao Y; Harvey A; O'Connor S; Coles C; Tsanaktsidis J; Kassiou M
Eur J Med Chem; 2014 Sep; 84():200-5. PubMed ID: 25019477
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning.
Weed MR; Polino J; Signor L; Bookbinder M; Keavy D; Benitex Y; Morgan DG; King D; Macor JE; Zaczek R; Olson R; Bristow LJ
PLoS One; 2017; 12(12):e0187609. PubMed ID: 29261656
[TBL] [Abstract][Full Text] [Related]
14. Aminobenzisoxazole compounds as agonists of α7 nicotinic acetylcholine receptors: a patent evaluation (WO 2017027600).
He Y; Shen J
Expert Opin Ther Pat; 2018 May; 28(5):429-436. PubMed ID: 29566578
[TBL] [Abstract][Full Text] [Related]
15. Identification and in vitro pharmacological characterization of a novel and selective α7 nicotinic acetylcholine receptor agonist, Br-IQ17B.
Tang JS; Xie BX; Bian XL; Xue Y; Wei NN; Zhou JH; Hao YC; Li G; Zhang LR; Wang KW
Acta Pharmacol Sin; 2015 Jul; 36(7):800-12. PubMed ID: 25948478
[TBL] [Abstract][Full Text] [Related]
16. Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.
Ravert HT; Dorff P; Foss CA; Mease RC; Fan H; Holmquist CR; Phillips E; McCarthy DJ; Heys JR; Holt DP; Wang Y; Endres CJ; Dannals RF; Pomper MG
Nucl Med Biol; 2013 Aug; 40(6):731-9. PubMed ID: 23680470
[TBL] [Abstract][Full Text] [Related]
17. Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists.
Arunrungvichian K; Fokin VV; Vajragupta O; Taylor P
ACS Chem Neurosci; 2015 Aug; 6(8):1317-30. PubMed ID: 25932897
[TBL] [Abstract][Full Text] [Related]
18. Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation.
Quadri M; Silnović A; Matera C; Horenstein NA; Stokes C; De Amici M; Papke RL; Dallanoce C
Eur J Med Chem; 2018 Dec; 160():207-228. PubMed ID: 30342362
[TBL] [Abstract][Full Text] [Related]
19. Cognitive improvements in a mouse model with substituted 1,2,3-triazole agonists for nicotinic acetylcholine receptors.
Arunrungvichian K; Boonyarat C; Fokin VV; Taylor P; Vajragupta O
ACS Chem Neurosci; 2015 Aug; 6(8):1331-40. PubMed ID: 25978789
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation.
Pismataro MC; Horenstein NA; Stokes C; Quadri M; De Amici M; Papke RL; Dallanoce C
Eur J Med Chem; 2020 Nov; 205():112669. PubMed ID: 32810771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
